Rheumatology Therapeutics Market Poised for 4.8 % Growth, Set to Hit $4.26 Billion by 2029

How Is the Rheumatology Therapeutics Market Projected to Grow, and What Is Its Market Size?
The size of the rheumatology therapeutics market has amplified significantly in the past few years. It is projected to escalate from $42.4 billion in 2024 to $44.61 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. The expansion during the historic period is credited to the increasing occurrence of rheumatologic disorders, growth in the global elderly population, heightened awareness of available treatments, advancements in biologic therapies, and improved healthcare accessibility in developing markets.

In the coming years, the rheumatology therapeutics market is projected to experience steady growth, expanding to $53.88 billion in 2029 with a compound annual growth rate (CAGR) of 4.8%. This projected growth during the forecast period is linked to the shift towards personalized medicine, increased uptake of biosimilars in rheumatology, rising investment in R&D, the integration of digital health technologies, and the approval of new therapies by regulatory bodies. Key trends in the forecast period encompass the growth of telemedicine and remote monitoring solutions, the development of targeted therapies for specific rheumatic conditions, a focus on patient-centric care models, the broadening of biologic treatments beyond monoclonal antibodies, and the adoption of value-based pricing models.

What Is Driving the Growth Trajectory of the Rheumatology Therapeutics Market?
Expectations are high for the rheumatology therapeutics market to expand due to the increasing occurrence of autoimmune disorders. Autoimmune diseases, where the immune system mistakenly targets and harms the body's own tissues, are on the rise due to a mix of genetic, environmental, and lifestyle factors. These conditions are also better understood and diagnosed thanks to heightened awareness and improved detection methods. To manage the inflammation caused by these diseases, alleviate associated symptoms, and prevent joint and tissue damage resulting from body attacks by the immune system, rheumatology therapeutics are essential. The Australian Institute of Health and Welfare, a government agency in Australia, in June 2024 reported that approximately 514,000 Australians, or 2.0% of the population, were living with rheumatoid arthritis in 2022. Rheumatoid arthritis represented 2.0% of the overall disease load and 16% of the burden of all musculoskeletal conditions in 2023. Consequently, the surge in autoimmune disorders is fueling the growth of the rheumatology therapeutics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp

Who Are the Major Industry Players Fueling Rheumatology Therapeutics Market Expansion?
Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.

Which Key Developments Are Influencing the Rheumatology Therapeutics Market?
Leading corporations in the field of rheumatology therapeutics are working on ground-breaking solutions such as intravenous (IV) formulations to uplift the efficacy of the treatment and make them more convenient for the patients. An intravenous (IV) formulation is a method where medication or a substance is directly administered into a vein through the use of a needle or catheter. As an example, Novartis AG, a pharmaceutical organization based in Switzerland reported in October 2023 that Cosentyx, an intravenous (IV) formulation, received approval from the US Food and Drug Administration (FDA). This particular formulation of Cosentyx is exclusively granted approval to treat adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). The formulation operates by specifically targeting and inhibiting interleukin-17A (IL-17A) and is the single non-tumor necrosis factor alpha (TNF-a) IV treatment available for these disorders.

How Is the Segmentation of the Rheumatology Therapeutics Market Defined?
The rheumatology therapeutics market covered in this report is segmented -

1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications

Subsegments:
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

What Is the Leading Region in the Rheumatology Therapeutics Market?
North America was the largest region in the rheumatology therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Rheumatology Therapeutics Global Market Report?

- Market Size Analysis: Analyze the Rheumatology Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Rheumatology Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Rheumatology Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Rheumatology Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.